Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
AVADEL PHARMACEUTICALS PLC (AVDL) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/29/2021 GN Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2021 Financial Results on May 10th
04/17/2021 GN Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting
03/04/2021 GN Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2021 Young Investigators Research Forum
03/02/2021 GN Avadel Pharmaceuticals Announces Publication of Once-Nightly FT218 Pharmacokinetic Studies
03/01/2021 GN Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
02/23/2021 GN Avadel Pharmaceuticals to Provide a Company Update and Report Fourth Quarter and Full Year 2020 Financial Results, on March 9th
02/10/2021 GN Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
12/16/2020 GN Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA
12/07/2020 GN Avadel Pharmaceuticals Appoints Dr. Jennifer Gudeman as Vice President of Medical and Clinical Affairs
11/23/2020 GN Avadel Pharmaceuticals to Present at Upcoming December 2020 Investor Conferences
11/11/2020 GN Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy